Sinicrope, F. A., Ou, F., Arnold, D., Peters, W., Behrens, R. J., Lieu, C. H., Matin, K., Cohen, D. J., Potter, S. L., Frankel, W. L., Shergill, A., Hsu, D., Reinacher-Schick, A. C., Zemla, T., Gatten, C. A., O'Reilly, E. M., Meyerhardt, J. A. (2025). Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502; ATOMIC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.17_suppl.lba1